WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
+13.42%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.8B
AUM Growth
+$1.65B
(+18%)
Cap. Flow
+$863M
Cap. Flow
% of AUM
7.98%
Top 10 Holdings %
Top 10 Hldgs %
14.33%
Holding
675
New
211
Increased
170
Reduced
126
Closed
150
Top Buys
| 1 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 2 |
TE Connectivity
TEL
|
$84.6M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
$78.6M |
| 4 |
Honeywell
HON
|
$72.8M |
| 5 |
Palo Alto Networks
PANW
|
$71.1M |
Top Sells
| 1 |
AbbVie
ABBV
|
$116M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$113M |
| 3 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$88.1M |
| 4 |
Permian Resources
PR
|
$75M |
| 5 |
SPLK
Splunk Inc
SPLK
|
$70.1M |
Sector Composition
| 1 | Healthcare | 38.65% |
| 2 | Technology | 22.91% |
| 3 | Industrials | 9.85% |
| 4 | Energy | 8.37% |
| 5 | Consumer Discretionary | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Cabaletta Bio
CABA
$155M
| $4.14M | 0.04% |
242,663
+1,210
| +0.5% | +$20.6K |
|
377
ARS Pharmaceuticals
SPRY
$995M
| $4.11M | 0.04% |
401,788
-259,626
| -39% | -$2.65M |
|
378
Intel
INTC
$107B
| $4.06M | 0.04% |
+91,892
| New | +$4.06M |
|
379
Geron
GERN
$893M
| $4.01M | 0.04% |
+1,214,570
| New | +$4.01M |
|
380
Reviva Pharmaceuticals
RVPH
$29.9M
| $3.99M | 0.04% |
1,055,009
+934,609
| +776% | +$3.53M |
|
381
10x Genomics
TXG
$1.74B
| $3.95M | 0.04% |
+105,261
| New | +$3.95M |
|
382
Brighthouse Financial
BHF
$2.48B
| $3.93M | 0.04% |
+76,256
| New | +$3.93M |
|
383
New Oriental
EDU
$7.98B
| $3.87M | 0.04% |
+44,574
| New | +$3.87M |
|
384
Xponential Fitness
XPOF
$299M
| $3.87M | 0.04% |
233,731
-188,470
| -45% | -$3.12M |
|
385
Enhabit
EHAB
$395M
| $3.85M | 0.04% |
+330,605
| New | +$3.85M |
|
386
Spyre Therapeutics
SYRE
$1.03B
| $3.81M | 0.04% |
+100,527
| New | +$3.81M |
|
387
Synaptics
SYNA
$2.7B
| $3.74M | 0.03% |
+38,367
| New | +$3.74M |
|
388
Trip.com Group
TCOM
$47.6B
| $3.7M | 0.03% |
+84,276
| New | +$3.7M |
|
389
Tourmaline Bio
TRML
$687M
| $3.6M | 0.03% |
+157,359
| New | +$3.6M |
|
|
MORF
390
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $3.52M | 0.03% |
+100,000
| New | +$3.52M |
|
391
HCA Healthcare
HCA
$98.5B
| $3.49M | 0.03% |
10,469
-56,321
| -84% | -$18.8M |
|
392
Lumentum
LITE
$10.4B
| $3.48M | 0.03% |
73,584
-68,182
| -48% | -$3.23M |
|
393
Domo
DOMO
$603M
| $3.45M | 0.03% |
386,818
+53,696
| +16% | +$479K |
|
394
SAP
SAP
$313B
| $3.36M | 0.03% |
17,207
+15,504
| +910% | +$3.02M |
|
|
ATYR
395
aTyr Pharma
ATYR
$550M
| $3.28M | 0.03% |
+1,681,279
| New | +$3.28M |
|
396
Akero Therapeutics
AKRO
$3.58B
| $3.24M | 0.03% |
+128,441
| New | +$3.24M |
|
397
Unity
U
$18.5B
| $3.21M | 0.03% |
120,240
-316,405
| -72% | -$8.45M |
|
398
Booz Allen Hamilton
BAH
$12.6B
| $3.14M | 0.03% |
+21,147
| New | +$3.14M |
|
399
Warby Parker
WRBY
$3.17B
| $3.13M | 0.03% |
230,108
+123,142
| +115% | +$1.68M |
|
400
First Advantage
FA
$2.79B
| $3.11M | 0.03% |
+191,884
| New | +$3.11M |
|